Inactivation of ARF/MDM2/TP53 signaling pathway occurred in 87% GBM patients, including deletion or mutation of ARF, amplifications of MDM2 or MDM4, deletion or mutation of TP53 [38]. The gene discussed is TP53; the disease is glioblastoma.